Brandes Investment Partners Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Charles Brandes and his team at Brandes Investment Partners exemplify timeless global value investing principles in their latest 13F filing. Their $13.1B Q4'2025 portfolio showcases disciplined adjustments across a diversified 190-position book, with notable additions in healthcare and aerospace alongside trims in financials and telecom, underscoring a focus on undervalued opportunities worldwide.
Portfolio Overview: Diversified Value with Patient Conviction
Portfolio Highlights (Q4'2025): - Market Value: $13.1B - Top 10 Holdings: 22.7% - Portfolio Size: 190 +9 - Average Holding Period: 20 quarters - Turnover: 11.1%
Brandes Investment Partners' portfolio maintains its hallmark diversification, with the top 10 holdings representing just 22.7% of the total $13.1B value—a deliberate structure that mitigates single-stock risk while pursuing global value opportunities. The addition of 9 new positions brings the total to 190, reflecting ongoing opportunity scouting in a market rife with mispricings. At 11.1% turnover, changes are measured, prioritizing long-term compounding over reactive trading.
This setup aligns with Brandes' foundational philosophy, rooted in Benjamin Graham's teachings and adapted for global markets. The 20-quarter average holding period—over five years—signals patience, allowing undervalued assets to realize intrinsic value. Investors tracking via Brandes' portfolio page on ValueSense can appreciate how low concentration in top holdings enables broad exposure to sectors like industrials, healthcare, and financials, balancing cyclical recoveries with defensive quality.
Top Holdings: Aerospace Adds, Financial Trims, and Healthcare Conviction
The Brandes portfolio leads with CAE Inc. (CAE) at 3.5% $461.1M, where they added 1.12%, betting on aviation training demand. Embraer S.A. (ERJ) follows at 2.5% $331.9M after a significant 12.37% reduction, potentially locking in gains amid jet production ramps. Additions continue with Open Text Corporation (OTEX) (2.3%, $296.7M, +1.19%) and Grifols, S.A. (GRFS) (2.2%, $289.4M, +6.32%), highlighting software and biotech value plays.
Trims dominate financials, including Citigroup Inc. (C) (2.1%, $275.5M, -9.92%), Millicom International Cellular S.A. (TIGO) (2.0%, $268.1M, -17.12%), and Wells Fargo & Company (WFC) (1.9%, $245.0M, -10.01%), suggesting profit-taking in recovering banks and emerging market telecom. Bullish moves shine in healthcare with Cigna Corporation (CI) (2.0%, $259.9M, +13.99%) and Merck & Co., Inc. (MRK) (2.0%, $259.7M, +1.85%), plus a minor trim in Kennametal Inc. (KMT) (2.2%, $290.7M, -0.92%). These 10 positions—all with changes—reveal active management within a stable core, blending international industrials like CAE and ERJ with U.S. stalwarts like CI and MRK.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
What the Portfolio Reveals
Brandes' Q4 moves paint a picture of global value hunting with risk-aware pruning:
- Sector tilt toward cyclicals and healthcare: Additions in aerospace (CAE, ERJ) and healthcare (CI, MRK, GRFS) signal bets on post-pandemic recovery and defensive growth.
- Financial sector discipline: Sharp reductions in C, WFC, and TIGO indicate valuation caution amid rate uncertainty.
- Geographic diversification: Heavy international exposure (Embraer in Brazil, Grifols in Spain, Millicom in Latin America) balances U.S. names, true to Brandes' global mandate.
- Low turnover risk management: 11.1% activity across 190 holdings avoids overtrading, with changes concentrated in top ranks for impact.
This strategy favors quality at discounts, with long holds (20 quarters average) compounding margins of safety.
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| CAE Inc. | $461.1M | 3.5% | Add 1.12% |
| Embraer S.A. | $331.9M | 2.5% | Reduce 12.37% |
| Open Text Corporation | $296.7M | 2.3% | Add 1.19% |
| Kennametal Inc. | $290.7M | 2.2% | Reduce 0.92% |
| Grifols, S.A. | $289.4M | 2.2% | Add 6.32% |
| Citigroup Inc. | $275.5M | 2.1% | Reduce 9.92% |
| Millicom International Cellular S.A. | $268.1M | 2.0% | Reduce 17.12% |
| Cigna Corporation | $259.9M | 2.0% | Add 13.99% |
| Merck & Co., Inc. | $259.7M | 2.0% | Add 1.85% |
| Wells Fargo & Company | $245.0M | 1.9% | Reduce 10.01% |
The table highlights Brandes' balanced approach: no single holding exceeds 3.5%, fostering diversification across 190 positions while top 10 capture 22.7%. Additions like CI +13.99% and GRFS +6.32% show conviction building in high-potential names, contrasted by trims in financials exceeding 10%—a classic value move to reallocate from maturing theses. This low-concentration top tier, paired with 11.1% turnover, demonstrates prudent scaling without chasing momentum.
Investment Lessons from Brandes Investment Partners
Brandes' Q4 portfolio distills decades of value wisdom into actionable principles:
- Global diversification unlocks hidden value: Exposure to non-U.S. names like ERJ and GRFS captures mispricings overlooked by domestic-focused investors.
- Trim winners, add to discounts: Reductions in C and WFC alongside builds in CAE emphasize selling strength to buy weakness.
- Patience compounds edges: 20-quarter holds prove long-term intrinsic value realization trumps short-term noise.
- Low turnover preserves alpha: 11.1% activity across 190 names avoids transaction costs, focusing energy on high-conviction adjustments.
- Margin of safety through breadth: 22.7% top-10 concentration balances risk, enabling steady returns in volatile markets.
Looking Ahead: What Comes Next?
Brandes enters 2026 with a robust $13.1B book, positioned for aviation rebound via CAE and ERJ, healthcare tailwinds in CI and MRK, and flexibility from recent trims. The +9 positions suggest cash deployment into undervalued cyclicals amid potential rate cuts. Opportunities may emerge in emerging markets or beaten-down tech like OTEX. Track via Brandes' portfolio on ValueSense to anticipate Q1 moves in a softening economy.
FAQ about Brandes Investment Partners Portfolio
Q: What were the biggest changes in Brandes' Q4 2025 13F filing?
A: Key adds included Cigna (CI) +13.99%, Grifols (GRFS) +6.32%, and CAE (CAE) +1.12%. Major trims hit TIGO -17.12%, ERJ -12.37%, and financials like C -9.92%.
Q: Why does Brandes maintain such low concentration in its top 10 holdings?
A: At 22.7%, the top 10 reflect a risk-managed value strategy across 190 positions, prioritizing broad exposure to global discounts over high-conviction bets, with 20-quarter holds building long-term returns.
Q: What sectors does Brandes favor based on Q4 moves?
A: Aerospace (CAE, ERJ), healthcare (CI, MRK), and software (OTEX) saw adds, while financials faced trims—signaling cyclical recovery plays.
Q: How can I track and follow Brandes Investment Partners' portfolio?
A: Use ValueSense's superinvestor tracker at https://valuesense.io/superinvestors/brandes-investment for 13F updates, visualizations, and change alerts. Note the 45-day filing lag means real-time positions may differ.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!